ZuzanaTothovaMD

Hematologic Oncology

Clinical Fellow in Medicine, Dana-Farber Cancer Institute

Dr. Tothova is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
450 Brookline Avenue, D0259
Boston, MA 02115
Phone+1 617-632-2933

Fax+1 617-632-2933

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2011
Harvard Medical SchoolClass of 2009

PubMed

2459 citations
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench, Nicolo Fusi, Meagan E Sullender, Mudra Hegde, Emma W Vaimberg
Nature Biotechnology. 2016-02-01
854 citations
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Jihye Paik, Ramya Kollipara, Gerald C. Chu, Hongkai Ji, Yonghong Xiao
Cell. 2007-01-26
174 citations
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML
Rishi V. Puram, Monika S. Kowalczyk, Carl G. de Boer, Rebekka K. Schneider, Peter Miller
Cell. 2016-04-07

Abstracts/Posters

Talazoparib Treatment Preferentially Depletes Cohesin-Mutant Clones in New In Vivo Models of Cohesin-Mutant Myeloid Diseases
Zuzana Tothova, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

A Community of ResearchersDecember 18th, 2020
Dana-Farber Receives $5 Million Gift to Create the Edward P. Evans Center for MDSSeptember 16th, 2019
Dana-Farber Physician Zuzana Tothova Receives Doris Duke Foundation Paragon Award for Research ExcellenceNovember 24th, 2023